{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:16:13Z","timestamp":1790356573638,"version":"4.1.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.rmed.2020.106161","type":"journal-article","created":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T17:18:10Z","timestamp":1600795090000},"page":"106161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Current perspectives on the immunopathogenesis of sarcoidosis"],"prefix":"10.1016","volume":"173","author":[{"given":"Silvia","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Birnie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2020.106161_bib1","first-page":"2663","article-title":"Cardiac manifestations of sarcoidosis: diagnosis and management","volume":"38","author":"Birnie","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.rmed.2020.106161_bib2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.mayocpiqo.2019.04.006","article-title":"Clinical manifestations, diagnosis, and treatment of sarcoidosis","volume":"3","author":"Ungprasert","year":"2019","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"10.1016\/j.rmed.2020.106161_bib3","first-page":"252","article-title":"Imaging of cardiac sarcoidosis","volume":"60","author":"Erthal","year":"2016","journal-title":"Q. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.rmed.2020.106161_bib4","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1148\/rg.2018180053","article-title":"PET\/CT in the diagnosis and workup of sarcoidosis: focus on atypical manifestations","volume":"38","author":"Akaike","year":"2018","journal-title":"Radiographics"},{"key":"10.1016\/j.rmed.2020.106161_bib5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijcard.2017.09.204","article-title":"How common is isolated cardiac sarcoidosis? Extra-cardiac and cardiac findings on clinical examination and whole-body (18)F-fluorodeoxyglucose positron emission tomography","volume":"253","author":"Juneau","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.rmed.2020.106161_bib6","series-title":"Diagnosing Isolated Cardiac Sarcoidosis: the Western Australian Cardiac Sarcoid Study","article-title":"The utility of whole body (18)F-FDG PET-CT","author":"Giudicatti","year":"2019"},{"key":"10.1016\/j.rmed.2020.106161_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12929-019-0537-6","article-title":"Host-microbe interactions in the pathogenesis and clinical course of sarcoidosis","volume":"26","author":"Inaoka","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.rmed.2020.106161_bib8","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.chest.2017.11.030","article-title":"The pathogenesis of pulmonary sarcoidosis and implications for treatment","volume":"153","author":"Patterson","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2020.106161_bib9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-019-0096-x","article-title":"Sarcoidosis","volume":"5","author":"Grunewald","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.rmed.2020.106161_bib10","first-page":"1","article-title":"New concepts in the pathogenesis of sarcoidosis","author":"Bennett","year":"2019","journal-title":"Expet Rev. Respir. Med."},{"key":"10.1016\/j.rmed.2020.106161_bib11","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1111\/all.13788","article-title":"Innate immunity in allergy","volume":"74","author":"Maeda","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.rmed.2020.106161_bib12","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.immuni.2019.08.005","article-title":"Inflammasomes: threat-assessment organelles of the innate immune system","volume":"51","author":"Evavold","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.rmed.2020.106161_bib13","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.007582","article-title":"Inflammasome formation in granulomas in cardiac sarcoidosis","volume":"12","author":"Kron","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"3","key":"10.1016\/j.rmed.2020.106161_bib14","doi-asserted-by":"crossref","first-page":"1900119","DOI":"10.1183\/13993003.00119-2019","article-title":"The NLRP3 inflammasome pathway is activated in sarcoidosis and involved in granuloma formation","volume":"55","author":"Huppertz","year":"2020","journal-title":"Eur Respir J."},{"key":"10.1016\/j.rmed.2020.106161_bib15","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.44519","article-title":"HIF-1alpha regulates IL-1 beta and IL-17 in sarcoidosis","volume":"8","author":"Talreja","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.rmed.2020.106161_bib16","first-page":"3424","article-title":"HIF1alpha promotes NLRP3 inflammasome activation in bleomycininduced acute lung injury","volume":"20","author":"Huang","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.rmed.2020.106161_bib17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.coi.2019.05.005","article-title":"HIF-1alpha as a central mediator of cellular resistance to intracellular pathogens","volume":"60","author":"Knight","year":"2019","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.rmed.2020.106161_bib18","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00109-018-1710-1","article-title":"Hypoxia-inducible factor-1alpha regulation of myeloid cells","volume":"96","author":"Stothers","year":"2018","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.rmed.2020.106161_bib19","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.3389\/fimmu.2018.01930","article-title":"Chemokine-induced macrophage polarization in inflammatory conditions","volume":"9","author":"Ruytinx","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.rmed.2020.106161_bib20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.humimm.2017.10.009","article-title":"Evidence for M2 macrophages in granulomas from pulmonary sarcoidosis: a new aspect of macrophage heterogeneity","volume":"79","author":"Shamaei","year":"2018","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.rmed.2020.106161_bib21","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/JLB.5A0718-280RR","article-title":"Mapping mononuclear phagocytes in blood, lungs, and lymph nodes of sarcoidosis patients","volume":"105","author":"Lepzien","year":"2019","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.rmed.2020.106161_bib22","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/s41590-019-0444-8","article-title":"The biology and functional importance of MAIT cells","volume":"20","author":"Godfrey","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.rmed.2020.106161_bib23","doi-asserted-by":"crossref","first-page":"13181","DOI":"10.1038\/s41598-019-49903-6","article-title":"Activation of mucosal-associated invariant T cells in the lungs of sarcoidosis patients","volume":"9","author":"Matsuyama","year":"2019","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.rmed.2020.106161_bib24","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10238-019-00578-3","article-title":"NK and NKT-like cells in granulomatous and fibrotic lung diseases","volume":"19","author":"Bergantini","year":"2019","journal-title":"Clin Exp Med."},{"key":"10.1016\/j.rmed.2020.106161_bib25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/qjmed\/hcx243","article-title":"Toll-like receptor 3 L412F polymorphism promotes a persistent clinical phenotype in pulmonary sarcoidosis","volume":"111","author":"Cooke","year":"2018","journal-title":"QJM"},{"key":"10.1016\/j.rmed.2020.106161_bib26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12931-018-0748-5","article-title":"G908R NOD2 variant in a family with sarcoidosis","volume":"19","author":"Besnard","year":"2018","journal-title":"Respir. Res."},{"key":"10.1016\/j.rmed.2020.106161_bib27","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.rmed.2018.01.004","article-title":"Neutrophil gelatinase-associated lipocalin in patients with sarcoidosis","volume":"138S","author":"Kato","year":"2018","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2020.106161_bib28","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/resp.13364","article-title":"Expression analysis of extracellular microRNA in bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis","volume":"23","author":"Kishore","year":"2018","journal-title":"Respirology"},{"issue":"6","key":"10.1016\/j.rmed.2020.106161_bib29","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/JLB.3MIR1117-459R","article-title":"miRNA regulation of innate immunity","volume":"103","author":"Momen-Heravi","year":"2018","journal-title":"J Leukoc Biol."},{"key":"10.1016\/j.rmed.2020.106161_bib30","first-page":"3078","article-title":"MicroRNA-146a inhibits NF-kappaB activation and pro-inflammatory cytokine production by regulating IRAK1 expression in THP-1 cells","volume":"18","author":"Zhou","year":"2019","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.rmed.2020.106161_bib31","doi-asserted-by":"crossref","first-page":"105794","DOI":"10.1016\/j.intimp.2019.105794","article-title":"MiR-150 attenuates LPS-induced acute lung injury via targeting AKT3","volume":"75","author":"Li","year":"2019","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.rmed.2020.106161_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206972","article-title":"Flow cytometric analysis of lymphocyte profiles in mediastinal lymphadenopathy of sarcoidosis","volume":"13","author":"Akao","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.rmed.2020.106161_bib33","doi-asserted-by":"crossref","first-page":"3642832","DOI":"10.1155\/2017\/3642832","article-title":"Local and systemic CD4(+) T cell exhaustion reverses with clinical resolution of pulmonary sarcoidosis","volume":"2017","author":"Hawkins","year":"2017","journal-title":"J Immunol Res"},{"key":"10.1016\/j.rmed.2020.106161_bib34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.rmed.2019.04.005","article-title":"Serum CXCL11 correlates with pulmonary outcomes and disease burden in sarcoidosis","volume":"152","author":"Arger","year":"2019","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2020.106161_bib35","doi-asserted-by":"crossref","first-page":"105822","DOI":"10.1016\/j.rmed.2019.105822","article-title":"CXCL9 and CXCL10 are differentially associated with systemic organ involvement and pulmonary disease severity in sarcoidosis","volume":"161","author":"Arger","year":"2019","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2020.106161_bib36","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.alit.2018.02.011","article-title":"TARC expression in the circulation and cutaneous granulomas correlates with disease severity and indicates Th2-mediated progression in patients with sarcoidosis","volume":"67","author":"Nguyen","year":"2018","journal-title":"Allergol. Int."},{"issue":"2","key":"10.1016\/j.rmed.2020.106161_bib37","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.alit.2019.09.005","article-title":"Circulating intermediate monocytes produce TARC in sarcoidosis","volume":"69","author":"Kishimoto","year":"2019","journal-title":"Allergol Int."},{"key":"10.1016\/j.rmed.2020.106161_bib38","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.3389\/fimmu.2017.01130","article-title":"Mass cytometry identifies distinct lung CD4(+) T cell patterns in lofgren's syndrome and non-lofgren's syndrome sarcoidosis","volume":"8","author":"Kaiser","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.rmed.2020.106161_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar8356","article-title":"PD-1 up-regulation on CD4(+) T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-beta 1 production","volume":"10","author":"Celada","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.rmed.2020.106161_bib40","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.3389\/fimmu.2019.02298","article-title":"The diverse function of PD-1\/PD-L pathway beyond cancer","volume":"10","author":"Qin","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.rmed.2020.106161_bib41","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s10147-019-01490-2","article-title":"Immune checkpoint inhibitor-induced sarcoidosis-like granulomas","volume":"24","author":"Rambhia","year":"2019","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.rmed.2020.106161_bib42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cyto.2015.02.002","article-title":"The role and modulation of CCR6+ Th17 cell populations in rheumatoid arthritis","volume":"74","author":"Paulissen","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.rmed.2020.106161_bib43","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01124-2017","article-title":"Increased T-helper 17.1 cells in sarcoidosis mediastinal lymph nodes","volume":"51","author":"Broos","year":"2018","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2020.106161_bib44","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.7150\/ijms.18838","article-title":"Extensively disturbance of regulatory T cells - Th17 cells balance in stage II pulmonary sarcoidosis","volume":"14","author":"Ding","year":"2017","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.rmed.2020.106161_bib45","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jaut.2018.07.012","article-title":"Molecular profiling of regulatory T cells in pulmonary sarcoidosis","volume":"94","author":"Kachamakova-Trojanowska","year":"2018","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/j.rmed.2020.106161_bib46","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jdermsci.2020.02.002","article-title":"Exploring the imbalance of circulating follicular helper CD4(+) T cells in sarcoidosis patients","volume":"97","author":"Ly","year":"2020","journal-title":"J Dermatol Sci."},{"key":"10.1016\/j.rmed.2020.106161_bib47","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41598-020-57741-0","article-title":"Imbalance in B cell and T Follicular helper cell subsets in pulmonary sarcoidosis","volume":"10","author":"Kudryavtsev","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.rmed.2020.106161_bib48","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3389\/fgene.2018.00503","article-title":"Next-generation sequencing based HLA typing: deciphering immunogenetic aspects of sarcoidosis","volume":"9","author":"Kishore","year":"2018","journal-title":"Front. Genet."},{"key":"10.1016\/j.rmed.2020.106161_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph16101830","article-title":"Genetic variants associated with FDNY WTC-related sarcoidosis","volume":"16","author":"Cleven","year":"2019","journal-title":"Int. J. Environ. Res. Publ. Health"},{"key":"10.1016\/j.rmed.2020.106161_bib50","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.3389\/fimmu.2019.02964","article-title":"Exome sequencing identifies susceptibility loci for sarcoidosis prognosis","volume":"10","author":"Lahtela","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.rmed.2020.106161_bib51","doi-asserted-by":"crossref","first-page":"1901450","DOI":"10.1183\/13993003.01450-2019","article-title":"Subpopulations of cells from bronchoalveolar lavage can predict prognosis in sarcoidosis","volume":"55","author":"Darlington","year":"2020","journal-title":"Eur Respir J."},{"key":"10.1016\/j.rmed.2020.106161_bib52","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12931-020-1327-0","article-title":"Lung CD4+ Valpha2.3+ T-cells in sarcoidosis cohorts with Lofgren's syndrome","volume":"21","author":"Darlington","year":"2020","journal-title":"Respir. Res."},{"key":"10.1016\/j.rmed.2020.106161_bib53","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/cei.13257","article-title":"Bronchoalveolar lavage characteristics correlate with HLA tag SNPs in patients with Lofgren's syndrome and other sarcoidosis","volume":"196","author":"Karakaya","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.rmed.2020.106161_bib54","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.rmed.2017.10.006","article-title":"Enhanced CD8(+) cytolytic T cell responses in the peripheral circulation of patients with sarcoidosis and non-Lofgren's disease","volume":"138S","author":"Parasa","year":"2018","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2020.106161_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193122","article-title":"Role of serum immunoglobulins for predicting sarcoidosis outcome: a cohort study","volume":"13","author":"Belhomme","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.rmed.2020.106161_bib56","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.3389\/fimmu.2018.01516","article-title":"In situ humoral immunity to vimentin in HLA-drb1*03(+) patients with pulmonary sarcoidosis","volume":"9","author":"Kinloch","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.rmed.2020.106161_bib57","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1007\/s10067-018-4183-2","article-title":"Significant elevation of the levels of B-cell activating factor (BAFF) in patients with sarcoidosis","volume":"37","author":"Ando","year":"2018","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.rmed.2020.106161_bib58","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12016-017-8666-8","article-title":"Cutaneous granulomatosis: a comprehensive review","volume":"54","author":"Terziroli Beretta-Piccoli","year":"2018","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.rmed.2020.106161_bib59","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/resp.13482","article-title":"Bidirectional association between tuberculosis and sarcoidosis","volume":"24","author":"Wang","year":"2019","journal-title":"Respirology"},{"issue":"10","key":"10.1016\/j.rmed.2020.106161_bib60","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/1346-8138.15042","article-title":"Identification of Mycobacterium tuberculosis and non-tuberculous mycobacteria from cutaneous sarcoidosis lesions by reverse blot hybridization assay","volume":"46","author":"Lee","year":"2019","journal-title":"J Dermatol."},{"key":"10.1016\/j.rmed.2020.106161_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192408","article-title":"Propionibacterium acnes-derived insoluble immune complexes in sinus macrophages of lymph nodes affected by sarcoidosis","volume":"13","author":"Suzuki","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.rmed.2020.106161_bib62","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s12026-019-09077-9","article-title":"Catalase expression of Propionibacterium acnes may contribute to intracellular persistence of the bacterium in sinus macrophages of lymph nodes affected by sarcoidosis","volume":"67","author":"Yamamoto","year":"2019","journal-title":"Immunol. Res."},{"key":"10.1016\/j.rmed.2020.106161_bib63","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.resinv.2015.02.005","article-title":"Propionibacterium acnes catalase induces increased Th1 immune response in sarcoidosis patients","volume":"53","author":"Yorozu","year":"2015","journal-title":"Respir Investig"},{"key":"10.1016\/j.rmed.2020.106161_bib64","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1164\/rccm.201705-0891OC","article-title":"Microbial lineages in sarcoidosis. A metagenomic analysis tailored for low-microbial content samples","volume":"197","author":"Clarke","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2020.106161_bib65","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12890-016-0332-z","article-title":"Is there any association between Sarcoidosis and infectious agents?: a systematic review and meta-analysis","volume":"16","author":"Esteves","year":"2016","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.rmed.2020.106161_bib66","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s12026-018-9052-1","article-title":"Specific features of immune complexes in patients with sarcoidosis and pulmonary tuberculosis","volume":"66","author":"Starshinova","year":"2018","journal-title":"Immunol. Res."},{"key":"10.1016\/j.rmed.2020.106161_bib67","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.autrev.2018.04.004","article-title":"Vimentin as antigenic target in autoimmunity: a comprehensive review","volume":"17","author":"Musaelyan","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.rmed.2020.106161_bib68","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.3389\/fimmu.2019.01923","article-title":"IL-17A can promote Propionibacterium acnes-induced sarcoidosis-like granulomatosis in mice","volume":"10","author":"Song","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.rmed.2020.106161_bib69","doi-asserted-by":"crossref","first-page":"19911","DOI":"10.1002\/jcp.28589","article-title":"Phosphoinositide 3-kinase\/protein kinase B inhibition restores regulatory T cell's function in pulmonary sarcoidosis","volume":"234","author":"Zhang","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.rmed.2020.106161_bib70","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.intimp.2018.08.030","article-title":"Interleukin 33 ameliorates disturbance of regulatory T cells in pulmonary sarcoidosis","volume":"64","author":"Zhang","year":"2018","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.rmed.2020.106161_bib71","doi-asserted-by":"crossref","first-page":"L617","DOI":"10.1152\/ajplung.00289.2017","article-title":"Transcriptional survey of alveolar macrophages in a murine model of chronic granulomatous inflammation reveals common themes with human sarcoidosis","volume":"314","author":"Mohan","year":"2018","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.rmed.2020.106161_bib72","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1165\/rcmb.2018-0053OC","article-title":"IL-13-regulated macrophage polarization during granuloma formation in an in vitro human sarcoidosis model","volume":"60","author":"Locke","year":"2019","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.rmed.2020.106161_bib73","doi-asserted-by":"crossref","first-page":"l5553","DOI":"10.1136\/bmj.l5553","article-title":"New advances in the management of pulmonary sarcoidosis","volume":"367","author":"Culver","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.rmed.2020.106161_bib74","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nri.2017.1","article-title":"Immune regulation by glucocorticoids","volume":"17","author":"Cain","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.rmed.2020.106161_bib75","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3389\/fimmu.2020.00779","article-title":"Derangement of metabolic and lysosomal gene profiles in response to dexamethasone treatment in sarcoidosis","volume":"11","author":"Talreja","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.rmed.2020.106161_bib76","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/cei.13438","article-title":"Changes in lung immune cells related to clinical outcome during treatment with infliximab for sarcoidosis","volume":"201","author":"Kullberg","year":"2020","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.rmed.2020.106161_bib77","doi-asserted-by":"crossref","first-page":"100575","DOI":"10.1016\/j.conctc.2020.100575","article-title":"Safety and efficacy of abatacept in patients with treatment-resistant SARCoidosis (ABASARC) - protocol for a multi-center, single-arm phase IIa trial","volume":"19","author":"Frye","year":"2020","journal-title":"Contemp Clin Trials Commun"},{"key":"10.1016\/j.rmed.2020.106161_bib78","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/acr2.1034","article-title":"Safety of abatacept versus placebo in rheumatoid arthritis: integrated data analysis of nine clinical trials","volume":"1","author":"Simon","year":"2019","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.rmed.2020.106161_bib79","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1080\/1744666X.2018.1527218","article-title":"Abatacept for the treatment of psoriatic arthritis","volume":"14","author":"Lubrano","year":"2018","journal-title":"Expet Rev. Clin. Immunol."},{"key":"10.1016\/j.rmed.2020.106161_bib80","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1080\/13543776.2019.1655541","article-title":"Retinoic acid receptor-related orphan receptor gamma-t (RORgammat) inhibitors in clinical development for the treatment of autoimmune diseases: a patent review (2016-present)","volume":"29","author":"Sun","year":"2019","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.rmed.2020.106161_bib81","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-036245","article-title":"Long-term effectiveness and safety of infliximab, golimumab and ustekinumab in patients with psoriatic arthritis from a Canadian prospective observational registry","volume":"10","author":"Rahman","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.rmed.2020.106161_bib82","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2174\/1574886315666200316113312","article-title":"Ustekinumab-induced sarcoidosis in a patient with psoriatic arthritis","volume":"15","author":"Kobak","year":"2020","journal-title":"Curr. Drug Saf."},{"key":"10.1016\/j.rmed.2020.106161_bib83","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s13256-019-2137-1","article-title":"Sarcoid- like Phenomenon - ustekinumab induced granulomatous reaction mimicking diffuse metastatic disease: a case report and review of the literature","volume":"13","author":"Gad","year":"2019","journal-title":"J. Med. Case Rep."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611120303012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611120303012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T12:05:38Z","timestamp":1760616338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611120303012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":83,"alternative-id":["S0954611120303012"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2020.106161","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current perspectives on the immunopathogenesis of sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2020.106161","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106161"}}